Medicare Part D coverage · aliskiren · RxCUI 1011739
aliskiren 300 MG Oral Tablet
Per the CMS 2026 Part D formulary file, aliskiren 300 MG Oral Tablet is covered by 5,052 Medicare Part D plans (100% of enrollable products), averaging Tier 2.7, with prior authorization required on 0.3% of covering formularies.
- 100%
- Plan coverage
- 5,052
- Plans covering
- T2.7
- Avg tier
- 0.3%
- Prior auth required
What the CMS Formulary Data Shows for aliskiren 300 MG Oral Tablet
Per the CMS 2026 Part D formulary file, aliskiren 300 MG Oral Tablet (RxNorm concept RXCUI 1011739, generic name aliskiren) appears on 328 distinct formulary files spanning 5,052 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.7.
Real-world access to aliskiren 300 MG Oral Tablet depends on utilization management as much as tier placement: 0.3% of covering formularies require prior authorization. 1.8% require step therapy. 45.1% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 6,966 Part D beneficiaries filled aliskiren 300 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $11,590,165 and an average per-beneficiary annual cost of $1,663.82. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry aliskiren 300 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 328
- Plans covering
- 5,052
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0.3% of formularies
- Step therapy required
- 1.8% of formularies
- Quantity limits
- 45.1% of formularies
2023 Medicare Spending
- Beneficiaries
- 6,966
- Total spending
- $11,590,165
- Avg per beneficiary
- $1,663.82
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering aliskiren 300 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | MO |
| UHC Dual Complete NE-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | NE |
| UHC Dual Complete KS-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | KS |
| UHC Dual Complete MO-S3 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | MO |
| UHC Dual Complete KS-Q1 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | KS |
| UHC Dual Complete TN-S001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| UHC Dual Complete TN-Y001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| UHC Dual Complete TN-Y2 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| AARP Medicare Advantage from UHC MI-0001 (PPO) | Unitedhealthcare Insurance Company | T1 | No | $0 | MI |
| UHC Dual Complete NM-Y1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete NM-S1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete NM-V1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete AZ-S001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | No | $0 | AZ |
| UHC Dual Complete AZ-Y001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | No | $0 | AZ |
| UHC Dual Complete VA-Y4 (PPO D-SNP) | Care Improvement Plus South Central Insurance Co. | T1 | No | $0 | VA |
| AARP Medicare Advantage from UHC AL-0001 (HMO-POS) | Unitedhealthcare OF THE Midlands, Inc. | T1 | No | $0 | AL |
| AARP Medicare Advantage from UHC CA-0002 (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
| UHC Sharp Medicare Advantage CA-001P (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
| AARP Medicare Advantage from UHC CA-003P (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is aliskiren 300 MG Oral Tablet covered by Medicare Part D?
Yes, aliskiren 300 MG Oral Tablet is covered by 5,052 Medicare Part D plans (100% of all Part D formularies).
What tier is aliskiren 300 MG Oral Tablet on Medicare Part D plans?
aliskiren 300 MG Oral Tablet averages Tier 2.7 across Part D plans, ranging from Tier 1 to Tier 6.
Does aliskiren 300 MG Oral Tablet require prior authorization?
0.3% of Part D formularies require prior authorization for aliskiren 300 MG Oral Tablet. Step therapy: 1.8%. Quantity limits: 45.1%.
How much does Medicare spend on aliskiren 300 MG Oral Tablet?
In 2023, total Medicare Part D spending on aliskiren 300 MG Oral Tablet was $11,590,165, covering 6,966 beneficiaries. The average spend per beneficiary was $1,663.82.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 3 ML insulin aspart, human 100 UNT/ML Cartridge [NovoLog] T2.7
- cyclosporine, modified 100 MG Oral Capsule T2.7
- Niacinamide insulin aspart, human 100 UNT/ML Injectable Solution [Fiasp] T2.7
- tazarotene 1 MG/ML Topical Cream T2.7
- tenofovir disoproxil fumarate 300 MG Oral Tablet T2.7
- cefazolin 500 MG Injection T2.7
Similar prior-authorization rate
- mitotane 500 MG Oral Tablet [Lysodren] 0.3% PA
- azithromycin 600 MG Oral Tablet 0.3% PA
- cilostazol 100 MG Oral Tablet 0.3% PA
- diazoxide 50 MG/ML Oral Suspension 0.3% PA
- minoxidil 10 MG Oral Tablet 0.3% PA
- ammonium lactate 120 MG/ML Topical Cream 0.3% PA